Home » Topics » Regulatory » Patents

Patents
RSS

Endothelin antagonists reported by Shionogi

May 17, 1996

Takeda claims NK1 ligands for respiratory indications

May 17, 1996

Byk Gulden reports PDE IV inhibitors for asthma, dermatoses

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

NMDA antagonists reported by Pfizer

May 17, 1996

Sankyo claims allosteric muscarinic effectors for AD

May 17, 1996

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

FO-2546F: ACAT inhibitor from Albophoma yamanashiensis

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...